Access to this activity requires either an RPA member password (see the RPA member area) or a paid (KEY ZONE) subscription and password to HDCN. If you are not an RPA member, to obtain an HDCN subscription, please register at this link, pay for your subscription on-line, and select a username and password. |
|
 |
Exploring the Role of the Nurse Practitioner and Physician Assistant in Kidney Patient Care (Part I)
Exploring the Role of the Nurse Practitioner and Physician Assistant in Kidney Patient Care (Part II)
Vascular Access/Graft Stenosis
| Lesley Dinwiddie, MSN, RN |
Economic Impact of the CKD Patient Population on the
Healthcare System
Optimal Anemia Management Across the Stages and Modalities
|
(click here) |
|
Treatment Options: Hemodialysis, Peritoneal Dialysis, Transplant
| Sharon Senft, RN, Kim Zuber, PA-C |
Appropriate Bone Mineral Metabolism Management in CKD: Can we impact survival?
RPA Guidelines in Palliative Care/Advance Directives
| Christy Price Rabetoy, NP, Jean L. Holley, MD |
Chronic Kidney Disease Educational Tools. Partnering For Improved CKD Care
Understanding Urea Kinetic Modeling
Cardiovascular Outcomes: Reducing Co-Morbidities in an At-Risk Population
|
(click here) |
|
| As the demands of an ever expanding population of kidney disease patients
grows, nephrologists are utilizing nurse practitioners and physician assistants to
assist in delivering the highest quality of care to this complicated group of patients.
In an effort to enhance the understanding of the numerous issues related to providing
sophisticated care in a challenging healthcare environment, the RPA and CME
Consultants, Inc. in partnership with the American Nephrology Nurses' Association
(ANNA) and the American Academy of Nephrology Physician Assistants (AANPA)
has created this program which emphasizes the ideal collaborative practice of
chronic kidney disease and end stage renal disease patients. |
At the conclusion of the workshop participants should be able to:
- Recognize the role of nurse practitioners and physician assistants as
part of the healthcare team in a nephrology practice.
- Assess various treatment modalities for end-stage renal disease patients.
- Identify which resources and educational tools are available to inform
kidney patients about their disease and treatment.
- Prepare the kidney patient for vascular access and proper maintenance of
the access site.
- Manage co-morbidities associated with the chronic kidney disease patient
including anemia management, lipid management, and phosphorous
management.
- Properly code, bill and document services provided to kidney disease patients.
- Minimize intradialytic complications.
|
Physician Assistants, Nurse Practitioners, and other healthcare providers working in Nephrology. |
|
See Pages for Part 1, and 2 for Faculty List |
|
| CME / CE RELATED INFORMATION |
This program was developed according to CME and CE guidelines and was accredited for Category 1 CME credit at time of presentation. However, this web-based presentation does not offer CME or CE credit.
The information presented is not intended to define a standard of care and should not be construed as doing so, nor should they be interpreted as prescribing an exclusive course of management.
Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of these guidelines is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation.
The views presented herein are those of the faculty and not necessarily those of the RPA nor of HDCN. This material is prepared based upon a review of multiple sources of information, but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter before relying solely upon the information contained within this material.
| FACULTY DISCLOSURE STATEMENTS: |
The
The RPA, ANNA, and HDCN have conflict of interest policies that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.
Please see individual speaker biographies for disclosure statements.
| DISCLOSURE OF UNLABELED USE: |
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The RPA, ANNA, and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
To complete this educational activity, the user will need Windows or Macintosh operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Acrobat Reader is required to print the lecture notes, and this can be download free from www.adobe.com.
For any questions concerning this activity please send an email to  or call HDCN at 630-325-3276 during normal business hours (Central Standard Time).
|
|
|
